---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-000009"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2025-01-03T23:59:59+00:00"
generated_at: "2026-05-28T13:09:53.216205+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience enters new exec agreement with President/CSO Docherty; base salary, 50% bonus, 15-mo severance

## Summary
- New agreement effective Jan 1, 2025, replaces prior 2022 pact; Docherty remains President and Chief Scientific Officer.
- Base salary subject to 5% annual increases on Jan 1, 2026 and Jan 1, 2027; performance bonuses up to 50% of base.
- Change of control: up to 24 months base salary plus 2% of affiliate sale value, payable within 90 days.
- Severance without cause or for good reason: 15 months base salary, increasing by 1 month per additional year to max 24 months.

## SEC filing metadata
- accession: 0001640334-25-000009
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2025-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033425000009/0001640334-25-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033425000009/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-000009
- JSON: https://secwatch.observer/filing/0001640334-25-000009.json
- Plain text: https://secwatch.observer/filing/0001640334-25-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.